{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:39:22Z","timestamp":1761183562248,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.dmpk.2023.100496","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T11:57:57Z","timestamp":1676462277000},"page":"100496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Population pharmacokinetics of duloxetine in Japanese pediatric patients with major depressive disorder"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5276-4358","authenticated-orcid":false,"given":"Risa Yokokawa","family":"Shibata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1979-4472","authenticated-orcid":false,"given":"Ryuji","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Uenaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsunori","family":"Kaibara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Wajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmpk.2023.100496_bib1","doi-asserted-by":"crossref","DOI":"10.1089\/cap.2021.0104","article-title":"Efficacy and safety of duloxetine in children and adolescents with major depressive disorder in Japan: a randomized double-blind placebo-controlled clinical trial followed by an open-label long-term extension trial","author":"Saito","year":"2022","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.dmpk.2023.100496_bib2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1089\/cap.2013.0096","article-title":"A\u00a0double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder","volume":"24","author":"Emslie","year":"2014","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.dmpk.2023.100496_bib3","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1089\/cap.2013.0146","article-title":"A\u00a0double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder","volume":"24","author":"Atkinson","year":"2014","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.dmpk.2023.100496_bib4","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s40262-014-0149-y","article-title":"Pharmacokinetics of orally administered duloxetine in children and adolescents with major depressive disorder","volume":"53","author":"Lobo","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.dmpk.2023.100496_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2125.2004.02157.x","article-title":"What is the best size descriptor to use for pharmacokinetic studies in the obese?","volume":"58","author":"Green","year":"2004","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.dmpk.2023.100496_bib6","doi-asserted-by":"crossref","first-page":"143e51","DOI":"10.1208\/s12248-011-9255-z","article-title":"Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models","volume":"13","author":"Bergstrand","year":"2011","journal-title":"AAPS J"},{"key":"10.1016\/j.dmpk.2023.100496_bib7","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/j.1552-4604.1997.tb04326.x","article-title":"Stability and performance of a population pharmacokinetic model","volume":"37","author":"Ette","year":"1997","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.dmpk.2023.100496_bib8","unstructured":"Pharmaceutical package insert: cymbalta capsules (Japan)."},{"issue":"3","key":"10.1016\/j.dmpk.2023.100496_bib9","doi-asserted-by":"crossref","DOI":"10.2165\/00003088-200948030-00005","article-title":"Population pharmacokinetics of orally administered duloxetine in patients: implications for dosing recommendation","volume":"48","author":"Lobo","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.dmpk.2023.100496_bib10","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/clpt.1992.203","article-title":"Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities","volume":"52","author":"Relling","year":"1992","journal-title":"Clin Pharmacol Ther"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436723000083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436723000083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:56:49Z","timestamp":1761163009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436723000083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":10,"alternative-id":["S1347436723000083"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2023.100496","relation":{},"ISSN":["1347-4367"],"issn-type":[{"type":"print","value":"1347-4367"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population pharmacokinetics of duloxetine in Japanese pediatric patients with major depressive disorder","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2023.100496","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100496"}}